Assignee
ORUM THERAPEUTICS INC
KR·4 granted patents·9 pending applications·7 citations·filing 2015–2025
Top patents by PatentIndex Score
13 records- 0186US10787487B2Cell/tissue-specific cell-penetrating antibodiesORUM THERAPEUTICS INC·Filed 2019·Granted Sep 29, 2020·4 cites·8 claims
- 0281US10851177B2Method for inhibiting intracellular activated RAS using intact immunoglobulin-type antibody having cytosol-penetrating ability and use thereofORUM THERAPEUTICS INC·Filed 2015·Granted Dec 1, 2020·2 cites·14 claims
- 0375US2026097117A1ConjugatesORUM THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0470US10844136B2Method for positioning, in cytoplasm, antibody having complete immunoglobulin form by penetrating antibody through cell membrane, and use for sameORUM THERAPEUTICS INC·Filed 2015·Granted Nov 24, 2020·1 cites·12 claims
- 0562US2023211008A1ConjugatesORUM THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0659US2025304563A1Activators of effector t cellsORUM THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0756US2025144230A1Linkers for use in antibody drug conjugatesORUM THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0855US2020385428A1Cell/tissue-specific cell-penetrating antibodiesORUM THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 0954US2024252671A1Neodegrader-anti-cd33 antibody conjugatesORUM THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1054US2023338564A1Neodegrader conjugatesORUM THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1153US2025090681A1Neodegrader conjugatesORUM THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1244US2020339681A1Antibody inhibiting activated ras in cell by internalizing into cytosol of cell, and use thereofORUM THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 1343US11155641B2Cytosol-penetrating antibody and use thereofORUM THERAPEUTICS INC·Filed 2017·Granted Oct 26, 2021·0 cites·27 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →